Literature DB >> 18632558

Listeria monocytogenes multidrug resistance transporters activate a cytosolic surveillance pathway of innate immunity.

Gregory T Crimmins1, Anat A Herskovits, Kai Rehder, Kelsey E Sivick, Peter Lauer, Thomas W Dubensky, Daniel A Portnoy.   

Abstract

To gain insight into the interaction of intracellular pathogens with host innate immune pathways, we performed an unbiased genetic screen of Listeria monocytogenes mutants that induced an enhanced or diminished host innate immune response. Here, we show that the major facilitator superfamily of bacterial multidrug resistance transporters (MDRs) controlled the magnitude of a host cytosolic surveillance pathway, leading to the production of several cytokines, including type I IFN. Mutations mapping to repressors of MDRs resulted in ectopic expression of their cognate transporters, leading to host responses that were increased up to 20-fold over wild-type bacteria, and a 20-fold decrease in bacterial growth in vivo. Mutation of one of the MDRs, MdrM, led to a 3-fold reduction in the IFN-beta response to L. monocytogenes infection, indicating a pivotal role for MdrM in activation of the host cytosolic surveillance system. Bacterial MDRs had previously been associated with resistance to antibiotics and other toxic compounds. This report links bacterial MDRs and host immunity. Understanding the mechanisms through which live pathogens activate innate immune signaling pathways should lead to the discovery of adjuvants, vaccines, and perhaps new classes of therapeutics. Indeed, we show that the mutants identified in this screen induced vastly altered type I IFN response in vivo as well.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18632558      PMCID: PMC2481368          DOI: 10.1073/pnas.0804170105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  A PEST-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity.

Authors:  A L Decatur; D A Portnoy
Journal:  Science       Date:  2000-11-03       Impact factor: 47.728

Review 2.  Structural mechanisms of multidrug recognition and regulation by bacterial multidrug transcription factors.

Authors:  Maria A Schumacher; Richard G Brennan
Journal:  Mol Microbiol       Date:  2002-08       Impact factor: 3.501

3.  Innate recognition of bacteria by a macrophage cytosolic surveillance pathway.

Authors:  Mary O'Riordan; Caroline H Yi; Ramona Gonzales; Kyung-Dall Lee; Daniel A Portnoy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-01       Impact factor: 11.205

Review 4.  Regulation of bacterial drug export systems.

Authors:  Steve Grkovic; Melissa H Brown; Ronald A Skurray
Journal:  Microbiol Mol Biol Rev       Date:  2002-12       Impact factor: 11.056

5.  Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes.

Authors:  Silvia Stockinger; Tilo Materna; Dagmar Stoiber; Lourdes Bayr; Ralf Steinborn; Thomas Kolbe; Hermann Unger; Trinad Chakraborty; David E Levy; Mathias Müller; Thomas Decker
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

6.  A specific gene expression program triggered by Gram-positive bacteria in the cytosol.

Authors:  Ramona L McCaffrey; Paul Fawcett; Mary O'Riordan; Kyung-Dall Lee; Edward A Havell; Patrick O Brown; Daniel A Portnoy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-21       Impact factor: 11.205

7.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses.

Authors:  Mitsutoshi Yoneyama; Mika Kikuchi; Takashi Natsukawa; Noriaki Shinobu; Tadaatsu Imaizumi; Makoto Miyagishi; Kazunari Taira; Shizuo Akira; Takashi Fujita
Journal:  Nat Immunol       Date:  2004-06-20       Impact factor: 25.606

8.  Type I interferon production enhances susceptibility to Listeria monocytogenes infection.

Authors:  Ryan M O'Connell; Supriya K Saha; Sagar A Vaidya; Kevin W Bruhn; Gustavo A Miranda; Brian Zarnegar; Andrea K Perry; Bidong O Nguyen; Timothy F Lane; Tadatsugu Taniguchi; Jeff F Miller; Genhong Cheng
Journal:  J Exp Med       Date:  2004-08-09       Impact factor: 14.307

9.  The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis.

Authors:  Zachary J Roberts; Nadege Goutagny; Pin-Yu Perera; Hiroki Kato; Himanshu Kumar; Taro Kawai; Shizuo Akira; Ram Savan; David van Echo; Katherine A Fitzgerald; Howard A Young; Lai-Ming Ching; Stefanie N Vogel
Journal:  J Exp Med       Date:  2007-06-11       Impact factor: 14.307

10.  Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes.

Authors:  Victoria Auerbuch; Dirk G Brockstedt; Nicole Meyer-Morse; Mary O'Riordan; Daniel A Portnoy
Journal:  J Exp Med       Date:  2004-08-09       Impact factor: 14.307

View more
  57 in total

1.  Listeria monocytogenes strain-specific impairment of the TetR regulator underlies the drastic increase in cyclic di-AMP secretion and beta interferon-inducing ability.

Authors:  Takeshi Yamamoto; Hideki Hara; Kohsuke Tsuchiya; Shunsuke Sakai; Rendong Fang; Motohiro Matsuura; Takamasa Nomura; Fumihiko Sato; Masao Mitsuyama; Ikuo Kawamura
Journal:  Infect Immun       Date:  2012-04-16       Impact factor: 3.441

2.  c-di-AMP secreted by intracellular Listeria monocytogenes activates a host type I interferon response.

Authors:  Joshua J Woodward; Anthony T Iavarone; Daniel A Portnoy
Journal:  Science       Date:  2010-05-27       Impact factor: 47.728

3.  Listeria monocytogenes strains selected on ciprofloxacin or the disinfectant benzalkonium chloride exhibit reduced susceptibility to ciprofloxacin, gentamicin, benzalkonium chloride, and other toxic compounds.

Authors:  Mira Rakic-Martinez; Douglas A Drevets; Vikrant Dutta; Vera Katic; Sophia Kathariou
Journal:  Appl Environ Microbiol       Date:  2011-10-14       Impact factor: 4.792

Review 4.  Sensing the messenger: the diverse ways that bacteria signal through c-di-GMP.

Authors:  Petya Violinova Krasteva; Krista Michelle Giglio; Holger Sondermann
Journal:  Protein Sci       Date:  2012-06-05       Impact factor: 6.725

Review 5.  A decade of research on the second messenger c-di-AMP.

Authors:  Wen Yin; Xia Cai; Hongdan Ma; Li Zhu; Yuling Zhang; Shan-Ho Chou; Michael Y Galperin; Jin He
Journal:  FEMS Microbiol Rev       Date:  2020-11-24       Impact factor: 16.408

6.  MPYS is required for IFN response factor 3 activation and type I IFN production in the response of cultured phagocytes to bacterial second messengers cyclic-di-AMP and cyclic-di-GMP.

Authors:  Lei Jin; Krista K Hill; Holly Filak; Jennifer Mogan; Heather Knowles; Bicheng Zhang; Anne-Laure Perraud; John C Cambier; Laurel L Lenz
Journal:  J Immunol       Date:  2011-08-03       Impact factor: 5.422

7.  Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice.

Authors:  Qing Zhu; Colt Egelston; Susan Gagnon; Yongjun Sui; Igor M Belyakov; Dennis M Klinman; Jay A Berzofsky
Journal:  J Clin Invest       Date:  2010-01-25       Impact factor: 14.808

Review 8.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

Review 9.  Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvants.

Authors:  Thomas W Dubensky; David B Kanne; Meredith L Leong
Journal:  Ther Adv Vaccines       Date:  2013-11

10.  Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: evolutionary considerations.

Authors:  John D Szumowski; Kristin N Adams; Paul H Edelstein; Lalita Ramakrishnan
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.